Micropos Medical AB (publ) (MPOS.ST)
- Previous Close
2.1500 - Open
2.1000 - Bid 1.9900 x --
- Ask 2.0200 x --
- Day's Range
2.0000 - 2.1000 - 52 Week Range
1.2550 - 3.5100 - Volume
29,981 - Avg. Volume
83,861 - Market Cap (intraday)
266.486M - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1260 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Micropos Medical AB (publ), a medical device company, develops technologies that enhance the precision in radiotherapy of cancer. Its products include Raypilot receiver, a plate with antennas that receive signals from the Raypilot Hypocath's integrated transmitter; Raypilot software, which interprets the data and presents the localization in 3D and in real-time with sub-millimetre accuracy; Raypilot Hypocath, a a temporary urinary catheter with an integrated transmitter; and Raypilot viewcath it resembles a Raypilot Hypocath without electronics and the transmission function. Micropos Medical AB (publ) was incorporated in 2003 and is based in Gothenburg, Sweden.
www.micropos.se8
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: MPOS.ST
View MorePerformance Overview: MPOS.ST
Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MPOS.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MPOS.ST
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-78.71%
Return on Equity (ttm)
-234.55%
Revenue (ttm)
3.82M
Net Income Avi to Common (ttm)
-21.87M
Diluted EPS (ttm)
-0.1260
Balance Sheet and Cash Flow
Total Cash (mrq)
7.97M
Total Debt/Equity (mrq)
2.52%
Levered Free Cash Flow (ttm)
-11.29M